mSEPT9 Blood Test (Epi proColon) for Colorectal Cancer Screening

Lin, Kenneth W. MD, MPH

Georgetown University Medical Center, Washington, District of Columbia

Address correspondence to Kenneth W. Lin, MD, MPH, at [email protected]. Reprints are not available from the author.

Author disclosure: No relevant financial affiliations.

American Family Physician 100(1):p 10-11, July 01, 2019.

Epi proColon is a blood test used for the detection of the methylated septin 9 (mSEPT9) gene. It is approved by the U.S. Food and Drug Administration (FDA) for colorectal cancer screening in people at average risk who have declined first-line screening tests.